Serial Number | 88984136 |
Word Mark | CANNA HEMP X |
Filing Date | Monday, November 5, 2018 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, May 25, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Medicated lip balm, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Medicated lip balm, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Orally-ingestible medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of dietary or nutritional supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Orally-ingestible medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of dietary or nutritional supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 20, 2018 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Infused MFG, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Las Vegas, NV 89117 |
Event Date | Event Description |
Friday, January 26, 2024 | WITHDRAWAL OF ATTORNEY GRANTED |
Friday, January 26, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
Friday, January 19, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, January 19, 2024 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
Friday, January 19, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, January 19, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, January 19, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Friday, January 19, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, May 25, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Thursday, May 25, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Thursday, May 25, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Thursday, February 2, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, February 2, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, February 2, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, November 30, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, November 30, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, November 30, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, May 31, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, May 31, 2022 | NON-FINAL ACTION E-MAILED |
Tuesday, May 31, 2022 | NON-FINAL ACTION WRITTEN |
Monday, April 25, 2022 | DIVISIONAL PROCESSING COMPLETE |
Wednesday, April 20, 2022 | DIVISIONAL REQUEST RECEIVED |
Monday, April 25, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, April 20, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, April 20, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, April 20, 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
Thursday, October 21, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, October 21, 2021 | NON-FINAL ACTION E-MAILED |
Thursday, October 21, 2021 | NON-FINAL ACTION WRITTEN |
Wednesday, October 13, 2021 | ASSIGNED TO EXAMINER |
Monday, May 24, 2021 | ASSIGNED TO EXAMINER |
Tuesday, May 11, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, May 10, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, May 10, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, February 23, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, February 23, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, February 23, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, February 23, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, February 23, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, November 12, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, November 12, 2020 | NON-FINAL ACTION E-MAILED |
Thursday, November 12, 2020 | NON-FINAL ACTION WRITTEN |
Wednesday, October 14, 2020 | DIVISIONAL PROCESSING COMPLETE |
Thursday, October 8, 2020 | DIVISIONAL REQUEST RECEIVED |
Thursday, October 8, 2020 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Thursday, October 8, 2020 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Thursday, October 8, 2020 | TEAS REQUEST TO DIVIDE RECEIVED |
Tuesday, August 25, 2020 | DIVISIONAL PROCESSING COMPLETE |
Wednesday, August 19, 2020 | DIVISIONAL REQUEST RECEIVED |
Thursday, August 20, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, August 19, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, August 19, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, August 19, 2020 | TEAS REQUEST TO DIVIDE RECEIVED |
Thursday, February 20, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, February 20, 2020 | NON-FINAL ACTION E-MAILED |
Thursday, February 20, 2020 | NON-FINAL ACTION WRITTEN |
Thursday, January 23, 2020 | DIVISIONAL PROCESSING COMPLETE |
Thursday, January 23, 2020 | DIVISIONAL PROCESSING COMPLETE |
Thursday, December 19, 2019 | DIVISIONAL REQUEST RECEIVED |
Friday, January 17, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, January 17, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, January 14, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Monday, January 13, 2020 | ASSIGNED TO LIE |
Thursday, December 19, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, December 19, 2019 | TEAS REQUEST TO DIVIDE RECEIVED |
Wednesday, December 18, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, December 18, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, August 8, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, August 8, 2019 | WITHDRAWAL OF ATTORNEY GRANTED |
Thursday, August 8, 2019 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
Wednesday, June 19, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, June 19, 2019 | NON-FINAL ACTION E-MAILED |
Wednesday, June 19, 2019 | NON-FINAL ACTION WRITTEN |
Wednesday, June 19, 2019 | ASSIGNED TO EXAMINER |
Sunday, November 25, 2018 | ASSIGNED TO EXAMINER |
Tuesday, November 20, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, November 9, 2018 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Friday, November 9, 2018 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Thursday, November 8, 2018 | NEW APPLICATION ENTERED |